| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.092 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.074 | 0.6 |